In an attempt to further improve overall profiles of the oxadiazine series of GSMs, in particular the hERG activity, conformational modifications of the core structure resulted in the identification of fused oxadiazepines such as 7i which had an improved hERG inhibition profile and was a highly efficacious GSM in vitro and in vivo in rats. These SAR explorations offer opportunities to identify potential drugs to treat Alzheimer's disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2012.11.055 | DOI Listing |
Publication Analysis
Top Keywords
fused oxadiazepines
8
alzheimer's disease
8
discovery fused
4
oxadiazepines gamma
4
gamma secretase
4
secretase modulators
4
modulators treatment
4
treatment alzheimer's
4
disease attempt
4
attempt improve
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!